Comparison the Effectiveness of Capecitabine in Breast Cancer Vs Gall Bladder Cancer

Abstract

Cancer is one of the most neglected diseases and is the leading cause of death worldwide. Breast cancer is the most common cancer and is the leading cause of death in women worldwide. In 2008, about 1.38 million new cases of breast cancer were diagnosed with symptoms of almost 50% of all breast cancer patients and about 60% of deaths occurring in developing countries. Breast cancer in women and prostate cancer in men are common worldwide. Worldwide; accounted for more than 27% of all cancers and approximately 15% of cancer deaths in women. Gallbladder cancer is one of the most common cancers in India with a high incidence in northern and central India. Gallbladder cancer is considered to be the fifth most common cancer and is one of the most aggressive cancers of the gastrointestinal tract. Most GBCs are epithelial adenocarcinomas. GBC has been reported to be three to five times more common in women than men. Worldwide; Clinical trials of targeted therapies and alternative therapies for breast and gallbladder cancer are ongoing and could offer significant new information on the treatment of this deadly disease, ultimately improving the effectiveness of treatment. For decades, there has been no worldwide neoadjuvant treatment or adjuvant treatment for used breast cancer and bile duct cancer. Therefore, adjuvant capecitabine was widely regarded as a standard adjuvant treatment. Adjuvant treatments including radiotherapy, chemotherapy and radiotherapy, as well as systemic chemotherapy can play a role in improving survival. This summarizes the current situation and future prospects for curative treatment for breast and gall bladder cancer. This article represents a comprehensive review of the literature on gallbladder and breast cancer literature examining epidemiology, pathology, diagnostic research and treatment with capecitabine and other drug combinations and also includes several therapies.
Keywords: breast cancer, gallbladder cancer, epidemiology, pathology, diagnosis and treatment, capecitabine.